Bringing multi-cancer early detection closer to everyday family medicine
At the Taiwan Association of Family Medicine Annual Meeting 2026, Gene Solutions Taiwan joined family medicine physicians, laboratory professionals, and clinical researchers to discuss the evolving role of multi-cancer early detection, or MCED, in preventive healthcare. Family medicine physicians are at the forefront of prevention. Through long-term patient relationships, they help individuals understand their cancer […]
Gene Solutions Vietnam and Ho Chi Minh City Oncology Hospital Join Forces to Expand the Application of Advanced Genomic Technologies in Cancer Care
Progress in precision oncology does not happen through innovation alone. It is built on scientific evidence, clinical collaboration, and a shared commitment to improving patient outcomes. With this vision in mind, on 27 July, Gene Solutions Vietnam and Ho Chi Minh City Oncology Hospital signed a Memorandum of Understanding (MOU) to strengthen collaboration in […]
Gene Solutions Showcases Global Evidence and Responsible Innovation in Prenatal and Women’s Genomic Health at ISPD 2026
As a Premier Partner, Gene Solutions presented Asia-led real-world evidence from large-scale NIPT-integrated carrier screening, alongside advances in AI-enabled pregnancy-risk assessment and minimally invasive molecular approaches to women’s health. SINGAPORE, July 22, 2026 — Gene Solutions, a global biotechnology company focused on accessible and responsible genomics, participated as a Premier Partner at the 30th International Conference […]
K-TRACK at ASCO Breakthrough 2026: Two Landmark ctDNA Studies Earn Top 40 Abstracts Honors for Advancing Precision Oncology in Real-world Setting
The ASCO Breakthrough meeting in Singapore convened global oncology leaders to highlight innovations shaping the future of cancer care. In addition to the remarkable real-world data on SPOT-MAS 10 multi-cancer early detection, two groundbreaking K-TRACK ctDNA-MRD studies from Gene Solutions were also recognized among the 40 highest-rated abstracts. These presentations captivated international oncologists and researchers […]
Gene Solutions’ SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
A blood-based cancer screening technology developed in Asia is gaining international attention after real-world data from more than 84,145 individuals were presented at ASCO Breakthrough 2026 and highlighted by the American Society of Clinical Oncology. For Gene Solutions, this milestone underscores the growing global relevance of Asia-led multi-cancer detection innovation. SINGAPORE, July 7, 2026 — […]
Next-generation AI-Powered Multi-Cancer Early Detection Takes Center Stage at Gene Solutions Hong Kong Symposium During MMMC 2026
The conversation around cancer screening is changing. For decades, cancer screening has largely focused on detecting individual cancers through separate tests. With advances in Artificial Intelligence (AI) and multi-omics technologies, new possibilities are emerging for identifying multiple cancers from a single blood draw — driving growing interest among healthcare professionals across the region. This topic took center stage at the Gene Solutions Hong Kong’s Symposium during the Multi-specialty […]
Introducing SPOT-MAS in Brazil: Advancing Access to Multi-Cancer Screening Through Genomic Innovation in Latin America.
São Paulo, June 25, 2026 — Gene Solutions Brazil and Bioma Genetics announced the introduction of SPOT-MAS in Brazil during an exclusive scientific event held in São Paulo, marking an important step in expanding access to innovative multi-cancer screening technologies across Latin America. The event welcomed more than 70 physicians, including oncologists and medical specialists from leading hospitals, cancer centers, and private practices […]
Gene Solutions Contributes Latest Prenatal Genomics Findings and Women’s Health Research at ISPD 2026
Gene Solutions will join the 30th International Conference on Prenatal Diagnosis and Therapy (ISPD) as a Premier Partner, contributing an Industry Symposium, an Industry Scientific Session, and five selected oral and poster presentations, highlighting advances in integrated prenatal genomic screening and methylation-based gynecologic cancer risk assessment. Gene Solutions is proud to participate in the 30th International Conference on Prenatal Diagnosis and Therapy, […]
SPOT-MAS 10 Real-World Data Highlighted by ASCO Ahead of ASCO Breakthrough 2026
Gene Solutions’ SPOT-MAS 10 real-world data was highlighted by ASCO ahead of ASCO Breakthrough 2026, recognizing evidence from 84,145 asymptomatic individuals across 6 Asian countries. Dr. Dang Nguyen also received the Conquer Cancer Merit Award. Singapore, 23 June 2026 — Gene Solutions is proud to announce that the latest real-world data on SPOT-MAS 10, its AI-powered, multi-omic blood-based test […]
ASCO 2026 RECAP | GENE SOLUTIONS PRESENT TWO CLINICAL STUDIES ADVANCING ctDNA APPLICATIONS IN CANCER CARE
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, USA, Gene Solutions, in collaboration with the Medical Genetics Institute (MGI), proudly presented two landmark scientific abstracts. These studies represent a major milestone in advancing liquid biopsy (ctDNA) applications across Southeast Asia, spanning from early-stage multi-cancer triage for symptomatic individuals to postoperative […]